Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Sleep Disorders

Free Subscription Articles published in J Neurol Retrieve available abstracts of 56 articles: HTML format

Single Articles

April 2024
1. MCWILLIAM O, Gramkow MH, Blaabjerg M, Clemmensen FK, et al
   Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review.
   J Neurol. 2024;271:1707-1716.
   PubMed     Abstract available
   
   
   
2. WANG R, Lian T, He M, Guo P, et al
   Clinical features and neurobiochemical mechanisms of olfactory dysfunction in patients with Parkinson disease.
   J Neurol. 2024;271:1959-1972.
   PubMed     Abstract available
   
   
   
3. TAHA HB, Bogoniewski A
   Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis.
   J Neurol. 2024;271:1680-1706.
   PubMed     Abstract available
   
   
   
4. PALAGINI L, Manni R, Liguori C, De Gennaro L, et al
   Evaluation and management of insomnia in the clinical practice in Italy: a 2023 update from the Insomnia Expert Consensus Group.
   J Neurol. 2024;271:1668-1679.
   PubMed     Abstract available
   
   
   March 2024
5. FEIGL B, Lewis SJG, Rawashdeh O
   Targeting sleep and the circadian system as a novel treatment strategy for Parkinson's disease.
   J Neurol. 2024;271:1483-1491.
   PubMed     Abstract available
   
   
   January 2024
6. JENSEN S, Abeler K, Friborg O, Rosner A, et al
   Insomnia and sleep-disordered breathing in FKRP-related limb-girdle muscular dystrophy R9. The Norwegian LGMDR9 cohort study (2020).
   J Neurol. 2024;271:274-288.
   PubMed     Abstract available
   
   
   December 2023
7. SHIRAISHI T, Yoshimaru D, Umehara T, Ozawa M, et al
   Interactive effect of orthostatic hypotension on gray matter atrophy associated with hyposmia and RBD in de novo Parkinson's disease.
   J Neurol. 2023;270:5924-5934.
   PubMed     Abstract available
   
   
   November 2023
8. BELLOFATTO M, Gentile L, Bertini A, Tramacere I, et al
   Daytime sleepiness and sleep quality in Charcot-Marie-Tooth disease.
   J Neurol. 2023;270:5561-5568.
   PubMed     Abstract available
   
   
   October 2023
9. LIU EN, Yang JH, Patel L, Arora J, et al
   Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19.
   J Neurol. 2023;270:4661-4672.
   PubMed     Abstract available
   
   
   September 2023
10. PARK DG, Kim JY, Kim MS, Kim MH, et al
    Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder.
    J Neurol. 2023;270:4393-4402.
    PubMed     Abstract available
    
    
    June 2023
11. COLLIA A, Iranzo A, Serradell M, Munoz-Lopetegi A, et al
    Former participation in professional football as an occupation in patients with isolated REM sleep behavior disorder leading to a synucleinopathy: a case-control study.
    J Neurol. 2023;270:3234-3242.
    PubMed     Abstract available
    
    
    
12. CICERO CE, Luca A, Mostile G, Donzuso G, et al
    Influence of RBD onset on the clinical characteristics of Parkinson's disease patients: a retrospective study.
    J Neurol. 2023;270:3171-3178.
    PubMed     Abstract available
    
    
    
13. CANNIZZARO M, Pieri V, Curti DG, Gueye M, et al
    Sporadic Fatal Insomnia presenting with agrypnia excitata and rapidly progressive dementia: a case report.
    J Neurol. 2023;270:3246-3251.
    PubMed    
    
    
    April 2023
14. GADOTH A, Devine MF, Pittock SJ, McKeon A, et al
    Sleep disturbances associated with DPPX autoantibodies: a case series.
    J Neurol. 2023 Apr 7. doi: 10.1007/s00415-023-11698.
    PubMed     Abstract available
    
    
    
15. WANG J, Tian Y, Qin C, Meng L, et al
    Impaired glymphatic drainage underlying obstructive sleep apnea is associated with cognitive dysfunction.
    J Neurol. 2023;270:2204-2216.
    PubMed     Abstract available
    
    
    March 2023
16. WANG S, Zheng X, Huang J, Lin J, et al
    Restless legs syndrome and cognitive function among adults: a systematic review and meta-analysis.
    J Neurol. 2023;270:1361-1370.
    PubMed     Abstract available
    
    
    February 2023
17. HENGEL H, Martus P, Faber J, Giunit P, et al
    The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors.
    J Neurol. 2023;270:944-952.
    PubMed     Abstract available
    
    
    December 2022
18. HAWKEN J, Robertson N
    Sleep disorders in Parkinson's disease.
    J Neurol. 2022;269:6685-6687.
    PubMed    
    
    
    October 2022
19. FERNANDES M, Mari L, Chiaravalloti A, Paoli B, et al
    (18)F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment.
    J Neurol. 2022;269:5356-5367.
    PubMed     Abstract available
    
    
    September 2022
20. BRAMICH S, King A, Kuruvilla M, Naismith SL, et al
    Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies.
    J Neurol. 2022;269:4684-4695.
    PubMed     Abstract available
    
    
    
21. CHU M, Xie K, Zhang J, Chen Z, et al
    Proposal of new diagnostic criteria for fatal familial insomnia.
    J Neurol. 2022;269:4909-4919.
    PubMed     Abstract available
    
    
    
22. NABIZADEH F, Pirahesh K, Valizadeh P
    REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson's disease: a cross-sectional and longitudinal study.
    J Neurol. 2022;269:4836-4845.
    PubMed     Abstract available
    
    
    May 2022
23. SPARASCI D, Gobbi C, Castelnovo A, Riccitelli GC, et al
    Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping.
    J Neurol. 2022 May 4. pii: 10.1007/s00415-022-11143.
    PubMed     Abstract available
    
    
    
24. WANG XT, Yu H, Liu FT, Zhang C, et al
    Associations of sleep disorders with cerebrospinal fluid alpha-synuclein in prodromal and early Parkinson's disease.
    J Neurol. 2022;269:2469-2478.
    PubMed     Abstract available
    
    
    
25. ADAM O, Azher S, Valachovic E, Hahn A, et al
    Narcolepsy genetic marker HLA DQB1*06:02 and excessive daytime sleepiness in Parkinson disease patients treated with dopaminergic agents.
    J Neurol. 2022;269:2430-2439.
    PubMed     Abstract available
    
    
    April 2022
26. YIANGOU A, Mitchell JL, Nicholls M, Chong YJ, et al
    Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT).
    J Neurol. 2022;269:1945-1956.
    PubMed     Abstract available
    
    
    March 2022
27. OLTRA J, Segura B, Uribe C, Monte-Rubio GC, et al
    Sex differences in brain atrophy and cognitive impairment in Parkinson's disease patients with and without probable rapid eye movement sleep behavior disorder.
    J Neurol. 2022;269:1591-1599.
    PubMed     Abstract available
    
    
    
28. MONTANARO E, Romagnolo A, Fabbri M, Artusi CA, et al
    Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson's disease.
    J Neurol. 2022;269:1538-1545.
    PubMed     Abstract available
    
    
    February 2022
29. KOCH J, Willemsen K, Dogan I, Rolke R, et al
    Quantitative sensory testing and norepinephrine levels in REM sleep behaviour disorder - a clue to early peripheral autonomic and sensory dysfunction?
    J Neurol. 2022;269:923-932.
    PubMed     Abstract available
    
    
    January 2022
30. FATEMEH G, Sajjad M, Niloufar R, Neda S, et al
    Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials.
    J Neurol. 2022;269:205-216.
    PubMed     Abstract available
    
    
    
31. GILAT M, Marshall NS, Testelmans D, Buyse B, et al
    A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials.
    J Neurol. 2022;269:125-148.
    PubMed     Abstract available
    
    
    November 2021
32. ZHANG G, Zhang L, Xia K, Zhuang Z, et al
    Daytime sleepiness might increase the risk of ALS: a 2-sample Mendelian randomization study.
    J Neurol. 2021;268:4332-4339.
    PubMed     Abstract available
    
    
    October 2021
33. TITOVA OE, Yuan S, Baron JA, Lindberg E, et al
    Sleep-disordered breathing-related symptoms and risk of stroke: cohort study and Mendelian randomization analysis.
    J Neurol. 2021 Oct 1. pii: 10.1007/s00415-021-10824.
    PubMed     Abstract available
    
    
    September 2021
34. CORDANI R, Veneruso M, Napoli F, Milanaccio C, et al
    Sleep disturbances in craniopharyngioma: a challenging diagnosis.
    J Neurol. 2021 Sep 14. pii: 10.1007/s00415-021-10794.
    PubMed     Abstract available
    
    
    
35. MARQUES A, Roquet D, Matar E, Taylor NL, et al
    Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders.
    J Neurol. 2021;268:3371-3380.
    PubMed     Abstract available
    
    
    August 2021
36. GUO Y, Liu FT, Hou XH, Li JQ, et al
    Predictors of cognitive impairment in Parkinson's disease: a systematic review and meta-analysis of prospective cohort studies.
    J Neurol. 2021;268:2713-2722.
    PubMed     Abstract available
    
    
    July 2021
37. FIELDS T, Schoser B, Oertel W, Strupp M, et al
    Acetyl-DL-leucine improves restless legs syndrome: a case report.
    J Neurol. 2021;268:2595-2596.
    PubMed    
    
    
    
38. SCHAEFFER E, Vaterrodt T, Zaunbrecher L, Liepelt-Scarfone I, et al
    Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson's Disease.
    J Neurol. 2021;268:2506-2514.
    PubMed     Abstract available
    
    
    June 2021
39. SIMONET C, Schrag A, Lees AJ, Noyce AJ, et al
    The motor prodromes of parkinson's disease: from bedside observation to large-scale application.
    J Neurol. 2021;268:2099-2108.
    PubMed     Abstract available
    
    
    April 2021
40. JIMENEZ-JIMENEZ FJ, Amo G, Alonso-Navarro H, Calleja M, et al
    Serum vitamin D, vitamin D receptor and binding protein genes polymorphisms in restless legs syndrome.
    J Neurol. 2021;268:1461-1472.
    PubMed     Abstract available
    
    
    
41. SUZUKI K, Suzuki S, Haruyama Y, Okamura M, et al
    Central sensitization in migraine is related to restless legs syndrome.
    J Neurol. 2021;268:1395-1401.
    PubMed     Abstract available
    
    
    March 2021
42. IRANZO A, Marrero-Gonzalez P, Serradell M, Gaig C, et al
    Significance of hyposmia in isolated REM sleep behavior disorder.
    J Neurol. 2021;268:963-966.
    PubMed     Abstract available
    
    
    February 2021
43. CHEN CY, Chen CL, Yu CC
    Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study.
    J Neurol. 2021 Feb 24. pii: 10.1007/s00415-021-10480.
    PubMed     Abstract available
    
    
    January 2021
44. MARELLI S, Castelnuovo A, Somma A, Castronovo V, et al
    Impact of COVID-19 lockdown on sleep quality in university students and administration staff.
    J Neurol. 2021;268:8-15.
    PubMed     Abstract available
    
    
    
45. XU Z, Anderson KN, Saffari SE, Lawson RA, et al
    Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal study.
    J Neurol. 2021;268:312-320.
    PubMed     Abstract available
    
    
    
46. ANDELIC N, Roe C, Brunborg C, Zeldovich M, et al
    Frequency of fatigue and its changes in the first 6 months after traumatic brain injury: results from the CENTER-TBI study.
    J Neurol. 2021;268:61-73.
    PubMed     Abstract available
    
    
    June 2020
47. DAFSARI HS, Ray-Chaudhuri K, Ashkan K, Sachse L, et al
    Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease.
    J Neurol. 2020;267:1830-1841.
    PubMed     Abstract available
    
    
    May 2020
48. HATTORI M, Tsuboi T, Yokoi K, Tanaka Y, et al
    Subjects at risk of Parkinson's disease in health checkup examinees: cross-sectional analysis of baseline data of the NaT-PROBE study.
    J Neurol. 2020;267:1516-1526.
    PubMed     Abstract available
    
    
    April 2020
49. ELFIL M, Ahmed N, Alapati A, Bahekar R, et al
    Suicidal risk and demoralization in Parkinson disease.
    J Neurol. 2020;267:966-974.
    PubMed     Abstract available
    
    
    February 2020
50. RATTAY TW, Boldt A, Volker M, Wiethoff S, et al
    Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4).
    J Neurol. 2020;267:369-379.
    PubMed     Abstract available
    
    
    
51. MASSEY TH, Robertson NP
    Restless legs syndrome: causes and consequences.
    J Neurol. 2020;267:575-577.
    PubMed    
    
    
    
52. LABERGE L, Gallais B, Auclair J, Dauvilliers Y, et al
    Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1.
    J Neurol. 2020;267:461-468.
    PubMed     Abstract available
    
    
    
53. MATAR E, Ehgoetz Martens KA, Halliday GM, Lewis SJG, et al
    Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology.
    J Neurol. 2020;267:380-389.
    PubMed     Abstract available
    
    
    
54. LU HT, Shen QY, Zhao QZ, Huang HY, et al
    Association between REM sleep behavior disorder and impulsive-compulsive behaviors in Parkinson's disease: a systematic review and meta-analysis of observational studies.
    J Neurol. 2020;267:331-340.
    PubMed     Abstract available
    
    
    January 2020
55. KEIR LHM, Breen DP
    New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson's disease.
    J Neurol. 2020;267:288-294.
    PubMed     Abstract available
    
    
    December 2019
56. GAETA AM, Benitez ID, Jorge C, Torres G, et al
    Prevalence of obstructive sleep apnea in Alzheimer's disease patients.
    J Neurol. 2019 Dec 12. pii: 10.1007/s00415-019-09668.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sleep Disorders is free of charge.